A published study involving University of Cincinnati experts has found significant sex differences in cardiovascular outcomes in patients with kidney failure who are on dialysis. Now the lead author is receiving an award for her work.

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends, according to the largest comprehensive analysis reporting long-term risks from such treatment relative to the risks faced by a control group of untreated men, just published in JAMA Oncology. The report says those considering PSA screening need quantitative information on the risks and benefits of treatment and of screening if they are to make truly informed decisions.